clozapine and 22q11-Deletion-Syndrome

Schizophrenia is a severely debilitating neurodevelopmental disorder. Establishing a causal link between circuit dysfunction and particular behavioral traits that are relevant to schizophrenia is crucial to shed new light on the mechanisms underlying the pathology. We studied an animal model of the human 22q11 deletion syndrome, the mutation that represents the highest genetic risk of developing schizophrenia. We observed a desynchronization of hippocampal neuronal assemblies that resulted from parvalbumin interneuron hypoexcitability. Rescuing parvalbumin interneuron excitability with pharmacological or chemogenetic approaches was sufficient to restore wild-type-like CA1 network dynamics and hippocampal-dependent behavior during adulthood. In conclusion, our data provide insights into the network dysfunction underlying schizophrenia and highlight the use of reverse engineering to restore physiological and behavioral phenotypes in an animal model of neurodevelopmental disorder.

Topics: 22q11 Deletion Syndrome; Action Potentials; Animals; Animals, Newborn; CA1 Region, Hippocampal; Clozapine; Disease Models, Animal; Female; Humans; Male; Mental Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Net; Neuregulins; Neurons; Nonlinear Dynamics; Parvalbumins; Prepulse Inhibition; Reflex, Startle; Schizophrenia